ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,301.13
1.21%
Dow Jones
43,221.55
1.65%
Gold vs US Dollar
2,697.19
1.08%
Brent Oil
81.425
-0.31%
Bitcoin
99,674.47
-0.84%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Syndax Pharmaceuticals Inc (SNDX) Share Price

SNDX Syndax Pharmaceuticals Inc

12.98
0.38 (3.02%)
16 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Syndax Pharmaceuticals Inc NASDAQ:SNDX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.38 3.02 12.98 11.92 13.09 13.16 12.71 13.07 1,479,039 00:59:58   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -209.36M -2.4527 -5.21 1.08B
 Type  Size  Price  Time  Units 
 20 300 12.98 00:59:07 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SNDX News
15/01/202522:34PRNUSIncyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
13/01/202512:00PRNUSSyndax Highlights Recent Accomplishments and Anticipated 2025 Milestones at the 43rd Annual J.P. Morgan Healthcare Conference
08/01/202502:20PRNUSKuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm
07/01/202512:00PRNUSSyndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
03/01/202521:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
20/12/202422:00EDGAR2Form 8-K - Current report
09/12/202412:30PRNUSSyndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial
Period
Draw mode
Data Downloads for SNDX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Syndax Pharmaceuticals Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads